Thursday, February 01, 2024 11:18:44 AM
Date // Short Interest // Milestone
01/12/2024 // 45,906,037
12/29/2023 // 46,139,791
12/15/2023 // 45,776,842 // Marketing Application Submitted
11/30/2023 // 46,647,939
11/15/2023 // 49,260,570
10/31/2023 // 55,750,380
10/13/2023 // 54,229,798
09/29/2023 // 52,330,376
09/15/2023 // 50,976,498 // Linda Liau Appointed to Scientific Advisory Board
08/31/2023 // 48,940,579 // Marketing Application Submission Announced within 30-45 days
08/15/2023 // 47,481,115
07/31/2023 // 44,998,078
07/14/2023 // 44,299,486
06/30/2023 // 43,316,947
06/15/2023 // 41,973,714
05/31/2023 // 40,738,041
05/15/2023 // 39,849,483
04/28/2023 // 37,419,389
04/14/2023 // 39,268,663
03/31/2023 // 39,133,732 // Commercial Manufacturing License Issued for Sawston
03/15/2023 // 39,268,213
02/28/2023 // 40,153,956
02/15/2023 // 39,063,970
01/31/2023 // 38,719,541
01/13/2023 // 41,300,593
12/30/2022 // 41,886,273
12/15/2022 // 41,783,315
11/30/2022 // 38,579,908 // Lawsuit Filed Against Market Makers
11/15/2022 // 27,453,945 // Clinical Trial Data Published in JAMA
10/31/2022 // 27,335,566
10/14/2022 // 27,532,363
09/30/2022 // 28,010,880
2022-09-15 // 29,057,926
2022-08-31 // 30,503,372 // Pediatric Investigation Plan Approved
2022-08-15 // 31,424,311
2022-07-29 // 31,803,013
2022-07-15 // 31,231,677 // Application For Commercial Manufacturing License Submitted
2022-06-30 // 32,876,739
2022-06-15 // 33,595,743
2022-05-31 // 31,736,044
2022-05-13 // 29,024,824 // Positive Top-line Data Released
2022-04-29 // 29,604,478
2022-04-14 // 28,766,916
2022-03-31 // 25,661,442
2022-03-15 // 24,381,784
2022-02-28 // 22,051,004
2022-02-15 // 20,060,226 // DCVax Production Commences at Sawston
2022-01-31 // 19,127,664
2022-01-14 // 17,767,836
2021-12-31 // 16,181,973
2021-12-15 // 15,605,232 // Investigational Manufacturing License Issued For Sawston
2021-11-30 // 13,284,932
2021-11-15 // 12,050,197
2021-10-29 // 12,555,107 // HTA License Issued For Sawston
2021-10-15 // 11,381,523
2021-09-30 // 11,412,754
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM